Danofloxacin is a synthetic fluoroquinolone antibiotic primarily used to treat bovine, porcine, and avian respiratory diseases by inhibiting bacterial DNA gyrase and topoisomerase IV. As a broad-spectrum… Read more
Danofloxacin is a synthetic fluoroquinolone antibiotic primarily used to treat bovine, porcine, and avian respiratory diseases by inhibiting bacterial DNA gyrase and topoisomerase IV. As a broad-spectrum antibacterial agent, its effective application relies on rigorous analytical testing to ensure product consistency. This category features high-quality Danofloxacin reference standards, including the mesylate form and stable isotope labelled compounds like Danofloxacin-d3 mesylate, which are essential tools for pharmaceutical laboratories. Chemists utilize these compounds for accurate impurity profiling, method validation, and the development of sensitive bioanalytical assays. By providing standardized materials for identifying pharmacopeial and non-pharmacopeial impurities, these products support precise metabolite studies and the overall quality control processes required for regulatory compliance in the analysis of this veterinary drug.